Equity
ITCI
Intra-Cellular Therapies (ITCI)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for ITCI to draw a line in its place.
Intra-Cellular Therapies (ITCI) institutional holders (13F)
SEC EDGAR0 of the 45 institutional funds we track reported a Intra-Cellular Therapies position for the quarter ended 30 Jun 2025; the latest of those filings landed 14 Aug 2025.
Congressional trades in Intra-Cellular Therapies (ITCI)
House disclosuresThe most recent congressional trade disclosed in Intra-Cellular Therapies is a sale by Josh Gottheimer (house, NJ), dated 03 Apr 2025.
Intra-Cellular Therapies (ITCI): frequently asked questions
How many institutions hold Intra-Cellular Therapies?
0 of the 45 institutional funds we track reported a Intra-Cellular Therapies position for the quarter ended 30 Jun 2025, per SEC Form 13F filings.
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
Sources
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR 13F filings
- House disclosuresU.S. House of Representatives financial disclosures